CANCER METASTATIC
Clinical trials for CANCER METASTATIC explained in plain language.
Never miss a new study
Get alerted when new CANCER METASTATIC trials appear
Sign up with your email to follow new studies for CANCER METASTATIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New mRNA treatment targets Hard-to-Treat cancers in early trial
Disease control Not yet recruitingThis early-phase study tests a new mRNA-based treatment for people with advanced solid tumors that have not responded to standard therapies. The treatment aims to control tumor growth by delivering a specific protein (IL-22BP) using a peptide carrier. The main goals are to check …
Matched conditions: CANCER METASTATIC
Phase: PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New combo therapy targets breast cancer brain metastases
Disease control Not yet recruitingThis early-phase trial tests whether combining the targeted drug trastuzumab deruxtecan (T-DXd) with precise radiation (SRS) is safe for people with HER2-positive breast cancer that has spread to the brain. Up to 20 participants will receive the drug by IV every three weeks along…
Matched conditions: CANCER METASTATIC
Phase: PHASE1 • Sponsor: Baptist Health South Florida • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Phone coaching aims to ease cancer symptoms for patients and caregivers
Symptom relief Not yet recruitingThis study tests whether adding telephone health coaching to a symptom management handbook helps reduce symptom burden and improve quality of life for people with metastatic breast, GI, or melanoma cancer and their caregivers. About 200 participants will be split into two groups:…
Matched conditions: CANCER METASTATIC
Phase: NA • Sponsor: University of Arizona • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC